Medical Marijuana, Inc. (MJNA)
OTCMKTS · Delayed Price · Currency is USD
0.0002
0.00 (0.00%)
Feb 11, 2026, 9:54 AM EST
Medical Marijuana Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 |
|---|---|---|---|---|---|---|
Period Ending | Jun '20 Jun 30, 2020 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 | Dec '17 Dec 31, 2017 | Dec '16 Dec 31, 2016 | Dec '15 Dec 31, 2015 |
Operating Revenue | 58.98 | 75.56 | 59.83 | 26.52 | 8 | 9.22 |
| 58.98 | 75.56 | 59.83 | 26.52 | 8 | 9.22 | |
Revenue Growth (YoY) | -20.71% | 26.30% | 125.56% | 231.37% | -13.15% | -36.55% |
Cost of Revenue | 12.5 | 17.83 | 19.49 | 8.11 | 3.37 | 3.91 |
Gross Profit | 46.48 | 57.73 | 40.34 | 18.41 | 4.64 | 5.3 |
Selling, General & Admin | 46.74 | 54 | 48.36 | 22.65 | 8.47 | 8.27 |
Research & Development | 0.2 | 0.43 | - | - | - | - |
Operating Expenses | 48.7 | 56.31 | 49.88 | 23.43 | 9.05 | 9.3 |
Operating Income | -2.22 | 1.42 | -9.54 | -5.02 | -4.42 | -3.99 |
Interest Expense | -0.99 | -1.09 | -1.82 | -7.02 | -11.11 | -3.05 |
Interest & Investment Income | 0.51 | 0.51 | 0.21 | 0.77 | 0 | 0.73 |
Other Non Operating Income (Expenses) | 1.99 | 2.18 | -0.4 | - | - | -1.41 |
EBT Excluding Unusual Items | -0.71 | 3.02 | -11.56 | -11.27 | -15.53 | -7.72 |
Impairment of Goodwill | - | - | - | -130.84 | - | 129.23 |
Gain (Loss) on Sale of Investments | 9.23 | 82.24 | -189.97 | - | -9.92 | -16.4 |
Asset Writedown | - | - | - | - | - | -73.47 |
Legal Settlements | 0.28 | -0.86 | -1.1 | -0.09 | -0.08 | -3.89 |
Other Unusual Items | - | - | - | - | -0.83 | -1.76 |
Pretax Income | 8.8 | 84.4 | -202.63 | -142.2 | -26.36 | 25.99 |
Earnings From Continuing Operations | 8.8 | 84.4 | -202.63 | -142.2 | -26.36 | 25.99 |
Earnings From Discontinued Operations | - | - | - | -5.91 | - | - |
Net Income to Company | 8.8 | 84.4 | -202.63 | -148.1 | -26.36 | 25.99 |
Minority Interest in Earnings | - | - | - | - | 0.45 | -0.01 |
Net Income | 8.8 | 84.4 | -202.63 | -148.1 | -25.91 | 25.97 |
Net Income to Common | 8.8 | 84.4 | -202.63 | -148.1 | -25.91 | 25.97 |
Shares Outstanding (Basic) | 3,866 | 3,755 | 3,562 | 3,271 | 3,125 | 2,867 |
Shares Outstanding (Diluted) | 3,866 | 3,755 | 3,562 | 3,271 | 3,125 | 2,867 |
Shares Change (YoY) | 5.82% | 5.42% | 8.91% | 4.66% | 9.02% | 60.83% |
EPS (Basic) | 0.00 | 0.02 | -0.06 | -0.05 | -0.01 | 0.01 |
EPS (Diluted) | 0.00 | 0.02 | -0.06 | -0.05 | -0.01 | 0.01 |
Free Cash Flow | 12.2 | 86.22 | -198.88 | -155.08 | -19.61 | 13.38 |
Free Cash Flow Per Share | 0.00 | 0.02 | -0.06 | -0.05 | -0.01 | 0.01 |
Gross Margin | 78.81% | 76.40% | 67.43% | 69.41% | 57.95% | 57.56% |
Operating Margin | -3.76% | 1.88% | -15.95% | -18.95% | -55.17% | -43.32% |
Profit Margin | 14.91% | 111.71% | -338.70% | -558.41% | -323.69% | 281.82% |
Free Cash Flow Margin | 20.69% | 114.11% | -332.43% | -584.71% | -245.05% | 145.24% |
EBITDA | - | 1.45 | -9.42 | -4.53 | -3.85 | -3.31 |
EBITDA Margin | - | 1.93% | -15.74% | -17.08% | -48.11% | -35.91% |
D&A For EBITDA | - | 0.03 | 0.12 | 0.49 | 0.56 | 0.68 |
EBIT | -2.22 | 1.42 | -9.54 | -5.02 | -4.42 | -3.99 |
EBIT Margin | -3.76% | 1.88% | -15.95% | -18.95% | -55.17% | -43.32% |
Advertising Expenses | - | - | - | 1.61 | 0.65 | 0.46 |
Updated Sep 5, 2020. Source: S&P Global Market Intelligence. Standard template. Financial Sources.